<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">27051302</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>04</Month>
            <Day>07</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1178-6930</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>9</Volume>
                    <PubDate>
                        <Year>2016</Year>
                    </PubDate>
                </JournalIssue>
                <Title>OncoTargets and therapy</Title>
                <ISOAbbreviation>Onco Targets Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1671-7</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2147/OTT.S101344</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of the study was to detect the expression of Sox10 in human nasopharyngeal carcinoma (NPC) and investigate the relationship between its expression and the clinicopathological characteristics of NPC patients.</AbstractText>
                <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Tumor specimens (n=105) were retrospectively collected from patients with NPC diagnosed between 2004 and 2005 who presented at Hunan Cancer Hospital. Immunohistochemistry analyses were performed to characterize the expression of Sox10 in NPC. Kaplan-Meier survival and Cox regression analyses were employed to evaluate the prognosis of 105 NPC patients.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The results showed that Sox10 was markedly overexpressed in human NPC tissues. Analysis of clinicopathological parameters showed that high Sox10 expression was significantly correlated with the clinical stage (P=0.032), T classification (P=0.034), and lymph node metastasis (P=0.03). Cox regression analyses further showed that Sox10 expression was an independent prognostic factor for overall survival (P=0.005). This is the first time Sox10 has shown its importance in predicting NPC progressiveness and survival outcomes.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Sox10 serves as a potential biomarker for NPC patients. It may hopefully become a novel therapeutic target for NPC patients.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Changsha, Hunan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Zhi-Gang</ForeName>
                    <Initials>ZG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Changsha, Hunan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Jiao</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Changsha, Hunan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zou</LastName>
                    <ForeName>Ren-Fang</ForeName>
                    <Initials>RF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Changsha, Hunan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xiao-Yan</ForeName>
                    <Initials>XY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Central South University, Changsha, Hunan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Guan-Min</ForeName>
                    <Initials>GM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qiu</LastName>
                    <ForeName>Yan-Fang</ForeName>
                    <Initials>YF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Changsha, Hunan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Changsha, Hunan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>03</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>Onco Targets Ther</MedlineTA>
            <NlmUniqueID>101514322</NlmUniqueID>
            <ISSNLinking>1178-6930</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">NPC</Keyword>
            <Keyword MajorTopicYN="N">Sox10</Keyword>
            <Keyword MajorTopicYN="N">prognosis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>4</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>4</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>4</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27051302</ArticleId>
            <ArticleId IdType="doi">10.2147/OTT.S101344</ArticleId>
            <ArticleId IdType="pii">ott-9-1671</ArticleId>
            <ArticleId IdType="pmc">PMC4807932</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2014 Sep 11;33(37):4613-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24662828</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2009 Feb 10;100(3):511-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19156145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol. 2011 Nov;46(11):1292-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21861142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2015 Sep 29;12(12):2035-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26365194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pigment Cell Melanoma Res. 2009 Aug;22(4):435-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19422606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1990 Jul 19;346(6281):245-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2374589</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pigment Cell Res. 2006 Aug;19(4):290-302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16827748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2015 Apr 21;5:9979</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25897700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013;8(2):e56324</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23424657</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Appl Immunohistochem Mol Morphol. 2015 Mar;23(3):215-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25265429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2013 Sep 15;73(18):5709-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23913827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 2008 May;40(5):499-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18443585</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2011 May 1;71(9):3410-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21531766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Cancer Res. 2014 Jul 16;4(4):312-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25057435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2013 Jul 23;109(2):444-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23799842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Res. 2008 Dec;18(12):1163-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19002157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2015 Mar;65(2):87-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25651787</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2003 May 19;22(20):3024-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12789277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2011 Jan 28;11:42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21276239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2004 Jan 2;556(1-3):236-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14706856</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2002 Jun 1;62(11):3020-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12036907</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Ther Targets. 2012 Sep;16(9):903-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22834733</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2006 Aug;6(8):593-602</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16862190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 2014 Aug;46(8):866-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24952746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Appl Immunohistochem Mol Morphol. 2014;22(2):142-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23958542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2012 Mar 2;148(5):1015-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22385965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mod Pathol. 2013 Aug;26(8):1041-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23558573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Dermatol. 2010 Aug;19(8):e89-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19845757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2008 Feb 1;68(3):650-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18245463</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>